International HealthCare
International HealthCare is a private, full-service Contract Research Organization providing Phase I-IV clinical trial management, regulatory strategy, and product development services to pharmaceutical, biotechnology, and medical device sponsors across the United States, Europe, Latin America, and Canada.
- Company typePrivate
- Founded2001
- HeadquartersNorwalk, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What International HealthCare does
International HealthCare (IHC Research) is a private, full-service Contract Research Organization (CRO) headquartered at 98 East Avenue, Norwalk, Connecticut. Founded in 2001, the company designs, monitors, and manages all phases of clinical trials (Phase I-IV) and provides regulatory strategy and product development services to pharmaceutical, biotechnology, and medical device sponsors worldwide. IHC has executed research on more than 150 compounds and over 10 successful Rx-to-OTC switches, with documented studies ranging up to 450 international centers and 6,600+ patient cardiovascular programs.
IHC's core offerings span project management, site monitoring, medical writing, regulatory affairs, safety/ethics review, data management and biostatistics, communication and training, and a dedicated SWAT Team ("Problem Solvers") service for troubled-trial rescue. The technology stack centers on Electronic Data Capture (EDC) partnerships with Oracle Clinical, XTrials, ETrials, and ProSoft Clinical (used on multiple major programs), a proprietary Project Tracker System for project management, and communication infrastructure on WebEx, Zoom, and Microsoft Teams. IHC is a member and sponsor of CDISC and operates 21 CFR Part 11-compliant qualified data centers with SOPs aligned to ICH guidelines. Therapeutic depth is concentrated in cardiovascular (65%-plus of US cardiovascular research patients covered), gastroenterology, pain management, CNS, infectious disease, and medical devices (IDE/PMA/510K).
The business model is professional services: project-based, multi-year contracts priced per trial scope (phase, therapeutic area, sites, geography, enrollment targets) with no standardized rate card. Go-to-market is direct enterprise field sales targeting mid-to-large pharma and biotech sponsors as well as medical device manufacturers, supported by a corporate website with case studies and a downloadable brochure plus conference presence (40+ presentations at industry symposiums). The leadership team is anchored by CEO Peter A. Fratarcangelo, Ph.D., and President William K. Tobin. Documented customer logos include Johnson & Johnson, Pfizer (Zantac-75, Angiomax), McNeil (Children's Motrin), Merck (Pepcid-AC, Tagamet-HB), Novartis (Maalox, Gas-X), Purdue Pharma (OxyContin), and Eisai (Aricept); no revenue, funding, or ARR figures are publicly disclosed.
International HealthCare firmographics
Firmographics- Name
- International HealthCare
- Legal name
- International HealthCare
- Website
- https://ihcresearch.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- International HealthCare is a private, full-service Contract Research Organization providing Phase I-IV clinical trial management, regulatory strategy, and product development services to pharmaceutical, biotechnology, and medical device sponsors across the United States, Europe, Latin America, and Canada.
- Ownership category
- akta.pro rank
International HealthCare industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industry
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where International HealthCare is headquartered
LocationHeadquarters
- HQ city
- Norwalk
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
International HealthCare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: IHC generates revenue through providing comprehensive contract research organization (CRO) services including project management, site management and monitoring, medical writing, regulatory affairs, safety/ethics review, data management/biostatistics, communication and training, and problem solver SWAT visits. Revenue is project-based, typically structured as contracts for managing all phases of clinical trials (Phase I to IV) for pharmaceutical, biotechnology, and medical device clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing for full-service CRO services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
International HealthCare product offering
Product offeringCore offering
International HealthCare (IHC) is a full-service Contract Research Organization (CRO) that designs, monitors, and manages all phases (Phase I through IV) of clinical trials for pharmaceutical, biotechnology, and medical device companies worldwide. The firm delivers integrated clinical research services spanning project management, site monitoring, medical writing, regulatory affairs, safety/ethics review, data management/biostatistics, and specialized SWAT team problem-solving, supported by CDISC-compliant EDC technology and a proprietary Project Tracker System.
Product overview
International HealthCare (IHC) is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services, regulatory strategy, and product development to pharmaceutical, biotechnology, and medical device industries worldwide. The company's core technology platform is the IHC Project Tracker System integrated with Electronic Data Capture (EDC) capabilities using multiple third-party platforms (Oracle Clinical, XTrials, ETrials, ProSoft Clinical EDC). IHC offers an integrated suite of services including Project Management, Site Monitoring, Medical Writing, Regulatory Affairs, Safety/Ethics Review, Communication & Training, Data Management/Biostatistics, and specialized SWAT Team Problem-Solving services. The company's clinical expertise spans Medical Devices & Imaging, Rx Clinical Trials (Phase I-IV), OTC Consumer Healthcare, and Rx to OTC Switch Services across therapeutic areas including cardiovascular, infectious disease, pain management, gastroenterology, respiratory conditions, and dermatology. IHC's distributed team operates throughout the United States, Europe, Latin America, and Canada.
Differentiator
Problem solved
Functional benefit
Products and services
- Project Management Services
Quantifiable outcome
- Faster enrollment completion - 180 subjects enrolled in under 17 months after SWAT team introduction (vs 2 years with only 30 subjects)
- +4 more outcomes
Companies that use International HealthCare
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
International HealthCare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
Feature3 records
International HealthCare partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Prosoft ClinicalcoreStrategic partnership with Prosoft to provide top quality Statisticians, Programmers and Medical Writers for clinical trials. IHC has utilized ProSoft Clinical EDC software on many major clinical programs with overwhelming success. The system provides seamless navigation and easy data entry processes critical to successful EDC implementation.
- Graphics 3minorIHC provides cost-effective printing and labeling services through alliance with Graphics 3. Graphics 3 has provided IHC with over 100,000 pages of clinical trial material including protocols, case report forms, and patient materials - all delivered timely with accuracy and highest quality.
- European CRO PartnershipscoreIHC has contractual partnerships with large full-service CROs throughout Europe and many other parts of the world to support large multi-country clinical programs. These alliances enable IHC to offer services that rival the largest CROs at competitive costs while maintaining single-point accountability through IHC management.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
International HealthCare competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-size, therapeutically-focused CRO with strong cardiovascular, oncology and medical device expertise. Comparable as a smaller, scientifically-driven alternative to mega-CROs serving similar pharma/biotech/medtech sponsors.
- Worldwide Clinical Trials: Mid-size global CRO with deep expertise in cardiovascular, metabolic, neuroscience and rare disease — directly comparable therapeutic footprint and sponsor profile to IHC.
- Premier Research: Specialty CRO focused on biotech, rare disease, oncology and medical devices. Comparable to IHC's mid-size, relationship-driven service model serving similar enterprise pharma and biotech sponsors.
- Cato Research (Cato SMS): Boutique CRO with deep regulatory and clinical development expertise including OTC switches and consumer health — a close size and capability analog to IHC's Rx-to-OTC franchise.
Broad incumbents
- ICON plc: Top-5 global CRO providing full-service Phase I-IV, bioanalytical and consulting across all major therapeutic areas — competes for the same enterprise pharma awards as IHC but at significantly greater scale.
- IQVIA: Largest global CRO and life sciences data/services platform. Competes with IHC across the full clinical trial lifecycle but operates at vastly greater scale and geographic reach.
- Labcorp (Covance Drug Development): Major CRO with global Phase I-IV capabilities and central laboratory services — overlaps with IHC's clinical trial management and lab data/biostatistics offerings.
- Charles River Laboratories: Large CRO/CDMO with discovery through clinical capabilities. Comparable enterprise pharma/biotech sponsor base though with much broader service breadth than IHC.
- Syneos Health: Full-service biopharmaceutical solutions organization combining CRO with commercial services. Direct overlap with IHC's clinical trial management for pharma/biotech/medtech sponsors.
Emerging players
- Clinipace Worldwide (CLIN-iQ): Mid-size, technology-enabled CRO focused on oncology, rare disease and emerging biopharma — a comparable emerging mid-market peer competing for similar biotech and specialty pharma RFPs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
International HealthCare social profiles
Digital presenceInternational HealthCare compliance and trust
Trust signalCompliance2 records
International HealthCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
International HealthCare leadership team
Management profileNumber of profiles
Profiles2 records
International HealthCare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
International HealthCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about International HealthCare
What does International HealthCare do?
International HealthCare (IHC) is a full-service Contract Research Organization (CRO) that designs, monitors, and manages all phases (Phase I through IV) of clinical trials for pharmaceutical, biotechnology, and medical device companies worldwide. The firm delivers integrated clinical research services spanning project management, site monitoring, medical writing, regulatory affairs, safety/ethics review, data management/biostatistics, and specialized SWAT team problem-solving, supported by CDISC-compliant EDC technology and a proprietary Project Tracker System.
Is International HealthCare a public or private company?
International HealthCare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was International HealthCare founded?
International HealthCare was founded in 2001. It employs 11 to 50 people.
Where is International HealthCare based?
International HealthCare is headquartered in Norwalk, United States, in the North America region.
How does International HealthCare make money?
One revenue line is on record: clinical Research Services.
Who are International HealthCare's main competitors?
Direct peers on record are Medpace, Worldwide Clinical Trials, Premier Research and Cato Research (Cato SMS). Broad incumbents are ICON plc, IQVIA, Labcorp (Covance Drug Development), Charles River Laboratories and Syneos Health. Clinipace Worldwide (CLIN-iQ) is listed as an emerging player.
Does International HealthCare have an API?
No public API is recorded for International HealthCare.
What industry is International HealthCare in?
International HealthCare's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 5417 and its SIC code is 8731.